MXPA03009595A - Uso de antagonistas del canal de sodio neuronal para control de ectoparasitos de animales homeotermicos. - Google Patents

Uso de antagonistas del canal de sodio neuronal para control de ectoparasitos de animales homeotermicos.

Info

Publication number
MXPA03009595A
MXPA03009595A MXPA03009595A MXPA03009595A MXPA03009595A MX PA03009595 A MXPA03009595 A MX PA03009595A MX PA03009595 A MXPA03009595 A MX PA03009595A MX PA03009595 A MXPA03009595 A MX PA03009595A MX PA03009595 A MXPA03009595 A MX PA03009595A
Authority
MX
Mexico
Prior art keywords
control
sodium channel
ectoparasites
neuronal sodium
channel antagonists
Prior art date
Application number
MXPA03009595A
Other languages
English (en)
Inventor
Heaney Kathleen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA03009595A publication Critical patent/MXPA03009595A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/34—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the groups, e.g. biuret; Thio analogues thereof; Urea-aldehyde condensation products
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/38—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the group >N—CO—N< where at least one nitrogen atom is part of a heterocyclic ring; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N61/00—Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agronomy & Crop Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion proporciona un metodo y composicion efectivos para la prevencion, alivio o control de parasitos externos en un humano o animal, por medio de la administracion de una cantidad profilacticamente, terapeuticamente o farmaceuticamente efectiva de un antagonista del canal de sodio neuronal a un humano o animal que necesite del mismo.
MXPA03009595A 2002-10-21 2003-10-20 Uso de antagonistas del canal de sodio neuronal para control de ectoparasitos de animales homeotermicos. MXPA03009595A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41988702P 2002-10-21 2002-10-21

Publications (1)

Publication Number Publication Date
MXPA03009595A true MXPA03009595A (es) 2004-10-15

Family

ID=32069964

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009595A MXPA03009595A (es) 2002-10-21 2003-10-20 Uso de antagonistas del canal de sodio neuronal para control de ectoparasitos de animales homeotermicos.

Country Status (25)

Country Link
US (1) US7906128B2 (es)
EP (2) EP1967067A3 (es)
JP (1) JP2004143172A (es)
KR (1) KR101110579B1 (es)
CN (1) CN100531728C (es)
AR (1) AR041668A1 (es)
AT (1) ATE405161T1 (es)
AU (2) AU2003255177B2 (es)
BR (1) BR0304618A (es)
CA (1) CA2444692C (es)
CO (1) CO5510023A1 (es)
CY (1) CY1108430T1 (es)
DE (1) DE60323028D1 (es)
DK (1) DK1413201T3 (es)
ES (1) ES2311677T3 (es)
HR (1) HRP20030856A2 (es)
ME (1) ME00571A (es)
MX (1) MXPA03009595A (es)
NZ (2) NZ567277A (es)
PL (1) PL362962A1 (es)
PT (1) PT1413201E (es)
RS (1) RS51054B (es)
SI (1) SI1413201T1 (es)
TW (1) TWI311465B (es)
ZA (1) ZA200308147B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906128B2 (en) 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
US7531186B2 (en) * 2003-12-17 2009-05-12 Merial Limited Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
KR100595446B1 (ko) * 2004-01-19 2006-07-03 삼성전자주식회사 디스플레이장치
TWI350728B (en) * 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions
UY28617A1 (es) * 2004-11-12 2006-06-30 Popley Pharma Ltda Nuevas composiciones
US20100095900A1 (en) * 2005-05-24 2010-04-22 Wyeth Llc Device and method for controlling insects
TWI368505B (en) * 2005-05-24 2012-07-21 Wyeth Corp Versatile high load concentrate compositions for control of ecto-parasites
US20060293260A1 (en) * 2005-05-24 2006-12-28 Wyeth Useful high load concentrate compositions for control of ecto-and endo-parasites
US7749527B2 (en) * 2005-05-24 2010-07-06 Wyeth Llc Gel compositions for control of ecto-parasites
TW200846029A (en) * 2007-02-09 2008-12-01 Wyeth Corp High dose, long-acting ectoparasiticide for extended control
CL2008001614A1 (es) * 2007-06-05 2008-08-08 Wyeth Corp Composicion parasiticida veterinaria que comprende un disolvente que no contiene hidroxilo, un estabilizador, amitraz y opcionalmente una lactona macrociclica y miristato de isopropilo; y su uso para tratar o controlar una infestacion o infeccion par
US9173728B2 (en) 2008-11-19 2015-11-03 Merial Inc. Multi-cavity container having offset indentures for dispensing fluids
CN102271672B (zh) 2008-11-19 2015-02-04 梅里亚有限公司 用于治疗寄生物感染的包含单独的或与甲脒组合的1-芳基吡唑的组合物
AU2010224685A1 (en) 2009-03-18 2011-11-03 Fidopharm, Inc. Parasiticidal formulation
KR102027723B1 (ko) 2010-12-27 2019-10-01 인터벳 인터내셔널 비.브이. 국소 적용 이속사졸린 제제
US9622478B2 (en) 2012-10-16 2017-04-18 Solano S.P. Ltd. Topical formulations for treating parasitic infestations
CN105168560A (zh) * 2015-07-22 2015-12-23 贵州谷丰生态农业发展有限责任公司 一种从鹅耳孔驱赶虱子的方法
US10512628B2 (en) 2016-04-24 2019-12-24 Solano S.P. Ltd. Dinotefuran liquid flea and tick treatment
SI3723739T1 (sl) 2017-12-15 2024-08-30 Tarsus Pharmaceuticals, Inc. Paraziticidni pripravki na osnovi izoksazolina in njihova uporaba za zdravljenje blefaritisa

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1176167A (en) 1980-03-06 1984-10-16 John J. Windheuser Use of n,n-diethyl-m-toluamide for enhancing skin permeation of bio-affecting agents
US4560553A (en) 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
GB8525447D0 (en) 1985-10-16 1985-11-20 Fbc Ltd Pesticidal compositions
US5116850A (en) 1987-11-30 1992-05-26 E. I. Du Pont De Nemours And Co. Heterocyclic pyrazoline carboxanilides
EP0462456B1 (en) 1990-06-16 1996-05-08 Nihon Nohyaku Co., Ltd. Hydrazinecarboxamide derivatives, a process for production thereof, and uses thereof
CA2093351A1 (en) 1990-10-05 1992-04-06 Charles R. Harrison Semicarbazone arthropodicides
DE69108356T2 (de) 1990-11-17 1995-07-20 Nihon Nohyaku Co Ltd Hydrazonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
US5462938A (en) 1990-12-21 1995-10-31 Annus; Gary D. Arthropodicidal oxadiazinyl, thiadiazinyl and triazinyl carboxanilides
US5250532A (en) 1991-04-11 1993-10-05 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides
JPH07165697A (ja) 1993-10-04 1995-06-27 Nissan Chem Ind Ltd セミカルバゾン化合物及び有害生物防除剤
JP3711581B2 (ja) 1995-03-31 2005-11-02 日産化学工業株式会社 セミカルバゾン誘導体及び有害生物防除剤
JPH09301947A (ja) 1996-05-17 1997-11-25 Nissan Chem Ind Ltd セミカルバゾン誘導体及び有害生物防除剤
US5968990A (en) 1997-10-14 1999-10-19 Isp Investments Inc. Water-dilutable, microemulsion concentrate and pour-on formulations thereof
JP4239298B2 (ja) * 1998-07-27 2009-03-18 住友化学株式会社 動物の外部寄生虫防除剤
WO2000029387A1 (fr) * 1998-11-12 2000-05-25 Sagami Chemical Research Center Derives de 2- anilino (3h)- pyrimidone, intermediaires dans la production de ces derniers, procede de production de ces derniers et pesticides contenant ces derniers comme ingredient actif
US5965137A (en) * 1998-11-16 1999-10-12 Advanced Medical Instruments Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases
AU765767B2 (en) * 1999-03-12 2003-09-25 Basf Aktiengesellschaft Synergistic insecticidal compositions
MY138864A (en) 1999-07-05 2009-08-28 Nihon Nohyaku Co Ltd Ant controllers and method for application thereof
AUPQ441699A0 (en) * 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
JP2001240583A (ja) * 1999-12-17 2001-09-04 Mitsubishi Chemicals Corp ジハロプロペニルオキシベンゼン誘導体及びこれを有効成分とする有害生物防除剤
JP2001240541A (ja) * 2000-03-02 2001-09-04 Kanto Kachiku Rinsho Center:Kk 動物外部寄生虫の駆除方法及び駆除剤
AU781682B2 (en) * 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
IL143225A (en) * 2000-05-24 2008-03-20 Pfizer Preparation of drugs containing α-amylase inhibitors to treat hyperacidity of the inner abdomen
JP5093429B2 (ja) * 2000-10-18 2012-12-12 日本農薬株式会社 動物用外部寄生性害虫防除剤及びその使用方法
US7906128B2 (en) 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
US20040122075A1 (en) 2002-12-16 2004-06-24 Wyeth N-phenyl-3-cyclopropylpyrazole-4-carbonitriles as ectoparasiticidal agents
EP1773121B1 (en) 2004-07-06 2011-02-09 Basf Se Liquid pesticide compositions
TWI350728B (en) 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions

Also Published As

Publication number Publication date
EP1413201B1 (en) 2008-08-20
CO5510023A1 (es) 2005-04-29
CN1496736A (zh) 2004-05-19
CA2444692C (en) 2012-01-10
US7906128B2 (en) 2011-03-15
AU2003255177A1 (en) 2004-05-06
ME00571A (en) 2011-12-20
PL362962A1 (en) 2004-05-04
BR0304618A (pt) 2004-08-31
EP1413201A2 (en) 2004-04-28
KR20040034542A (ko) 2004-04-28
EP1967067A3 (en) 2009-05-06
SI1413201T1 (sl) 2008-12-31
HRP20030856A2 (en) 2005-02-28
TW200418388A (en) 2004-10-01
AU2003255177B2 (en) 2009-10-08
ZA200308147B (en) 2005-04-20
CY1108430T1 (el) 2014-04-09
DE60323028D1 (de) 2008-10-02
AU2009210409A1 (en) 2009-09-10
PT1413201E (pt) 2008-10-28
KR101110579B1 (ko) 2012-02-15
DK1413201T3 (da) 2008-11-10
ES2311677T3 (es) 2009-02-16
TWI311465B (en) 2009-07-01
ATE405161T1 (de) 2008-09-15
RS51054B (sr) 2010-10-31
EP1413201A3 (en) 2004-06-23
EP1967067A2 (en) 2008-09-10
NZ567277A (en) 2009-12-24
CA2444692A1 (en) 2004-04-21
US20040116419A1 (en) 2004-06-17
JP2004143172A (ja) 2004-05-20
NZ550771A (en) 2008-06-30
AR041668A1 (es) 2005-05-26
CN100531728C (zh) 2009-08-26
YU82503A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
MXPA03009595A (es) Uso de antagonistas del canal de sodio neuronal para control de ectoparasitos de animales homeotermicos.
PL378927A1 (pl) Stałe postacie dawkowane do żucia i sposoby dostarczania środków czynnych do trudno dostępnych powierzchni zębów
WO2005107726A3 (en) Method for the treatment of back pain
DE60038290D1 (de) Opioidantagonisthaltige zusammensetzung zur erhöhung der analgetischen wirksamkeit von tramadol und verringerung von ihre nebenwirkungen
DK1414451T3 (da) Opioidagonistformuleringer med frigivelig og sekvenstreret antagonist
AR040014A1 (es) Combinacion de compuestos organicos
MX2007005570A (es) Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y manejo de padecimientos parasiticos.
WO2004017896A3 (en) Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist
WO2003106629A3 (en) TREATMENT OF VITAMIN D INFLUENCED DISEASES
BRPI0412557A (pt) forma de dosagem farmacêutica de eventos cardiovasculares
WO2004006859A3 (en) Platinum compound
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
MX360150B (es) Antagonista del receptor de angiotensina ii para la prevencion o el tratamiento de enfermedades generalizadas en gatos.
NO20051658L (no) Terapeutisk behandling
IT1302682B1 (it) Composizioni farmaceutiche orali contenenti buprenorfina
WO2001001972A3 (en) SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
EP1534295A4 (en) FORMULATIONS AND METHODS OF ADMINISTRATION OF CEPHALOTAXINS, INCLUDING HOMOHARRINGTONIN
AU2003267088A8 (en) Chemokine receptor antagonists as therapeutic agents
AP2002002501A0 (en) Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
WO2003051290A3 (en) Treating b-cell mediated diseases by modulating dr6 activity
ID29818A (id) Penggunaan antagonis reseptor angiotensin ii untuk mengobati infarksi miokardial
MXPA04008460A (es) Composiciones farmaceuticas de un inhibidor de pde4 o pde3/4 y un antagonista de receptor de histamina.
WO2000053148A3 (en) Methods and compositions for treating erectile dysfunction

Legal Events

Date Code Title Description
FG Grant or registration